MARATTO

article · The Lancet Microbe

Bedaquiline resistance in patients with Xpert MTB/RIF Ultra-tested rifampicin-resistant tuberculosis in the Western Cape, South Africa: a prospective study

In plain language

The abstract on record is too brief for a reliable plain-language summary, so none has been generated.

Abstract

The National Institute of Allergy and Infectious Diseases (at the National Institutes of Health) and Unitaid.

Research topics

  • Tuberculosis Research and Epidemiology
  • Pneumonia and Respiratory Infections
  • Pneumocystis jirovecii pneumonia detection and treatment

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1016/j.lanmic.2025.101293

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.